(Q67489958)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318739%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318739%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

5 December 2023

author name string

E. Alba

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318739

12 September 2022

J. J. Breton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318739

12 September 2022

L. Alonso

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318739

12 September 2022

G. Paredes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318739

12 September 2022

J. Belon

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318739

12 September 2022

P. Ballesteros

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318739

12 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1318739

12 September 2022

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318739%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

14 September 2019

http://annonc.oxfordjournals.org/cgi/content/abstract/3/1/31

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318739

https://doi.org/10.1093/oxfordjournals.annonc.a058062

12 September 2022

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1318739

https://api.elsevier.com/content/article/PII:S0923753419651161?httpAccept=text/xml

5 December 2023

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

https://api.elsevier.com/content/article/PII:S0923753419651161?httpAccept=text/plain

5 December 2023

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

http://academic.oup.com/annonc/article-pdf/3/1/31/387822/3-1-31.pdf

5 December 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

5 December 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318739%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318739%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318739%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

31-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318739%20AND%20SRC:MED&resulttype=core&format=json

Small cell lung cancer 1973–1983: Early progress and recent obstacles

14 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Current status of therapy for small cell carcinoma of the lung

5 December 2023

2

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma

5 December 2023

4

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs

5 December 2023

6

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial

5 December 2023

10

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada

5 December 2023

11

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung

5 December 2023

12

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group

5 December 2023

13

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

High-dose cyclophosphamide in small-cell carcinoma of the lung

5 December 2023

14

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Intensive induction chemotherapy for small cell anaplastic carcinoma of the lung

5 December 2023

15

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma

5 December 2023

16

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

High-dose induction chemotherapy with cyclophosphamide, etoposide, and cisplatin for extensive-stage small-cell lung cancer

5 December 2023

17

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer

5 December 2023

18

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer

5 December 2023

19

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation

5 December 2023

20

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study

5 December 2023

21

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma

5 December 2023

22

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Reporting results of cancer treatment

5 December 2023

23

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

A preliminary report: concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer

5 December 2023

24

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial

5 December 2023

26

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party

5 December 2023

27

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: a Southwest Oncology Group pilot study

5 December 2023

28

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancer

5 December 2023

29

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Combination chemotherapy using high or low dose methotrexate for small cell carcinoma of the lung — A randomised trial

5 December 2023

30

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

5 December 2023

32

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapy

5 December 2023

33

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer

5 December 2023

34

1 reference

https://api.crossref.org/works/10.1093/OXFORDJOURNALS.ANNONC.A058062

5 December 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1318739%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

1 reference